Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Antisense oligodeoxynucleotide Anxiety

Landgraf R, Gerstberger R, Montkowski A, Probst JC, Wotjak CT, Holsboer F, Engelmann M (1995) VI vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J Neimosci 15 4250-4258... [Pg.137]

Wahlestedt C, Pich EM, Koob GF, et al Modulation of anxiety and neuropeptide Y-Yl receptors by antisense oligodeoxynucleotides. Science 259 528-531, 1993 Waka T, Fukada N Pharmacologic profile of a new anxiolytic, DN 2327 effect of R015-1788 and interaction with diazepam in rodents. Psychopharmacology 103 314-322, 1991... [Pg.764]

Skutella T, Montkowski A, Stohr T, Probst JC, Landgraf R, Holsboer F, Jirikowski GF (1994) Corticotropin-releasing hormone oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats. Cell Mol Neurobiol 14 579-588 Skutella T, Probst JC, Renner U, Holsboer F, Behl C (1998) Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety. Neuroscience 85 795-805... [Pg.366]

See other pages where Antisense oligodeoxynucleotide Anxiety is mentioned: [Pg.129]    [Pg.137]    [Pg.341]    [Pg.363]    [Pg.363]    [Pg.368]    [Pg.524]    [Pg.684]    [Pg.14]    [Pg.38]    [Pg.86]    [Pg.401]   
See also in sourсe #XX -- [ Pg.53 , Pg.55 ]



SEARCH



Antisense

Antisense oligodeoxynucleotide

Antisense oligodeoxynucleotides

Oligodeoxynucleotide

Oligodeoxynucleotides

© 2024 chempedia.info